Skip to: site menu | section menu | main content

Reductil (Meridia) : The Slimming Pill

Information for consumers and GPs
Currently viewing: Reductil » Home

Reductil information resource

Navigation:

Latest News
Technical Info
Side Effects
Contraindications
Info for GPs
Disclaimer
Links

Articles:

Reductil (sibutramine) Nice Prescription Recommendations
Back to top
Back to top
This site does not represent and is not affiliated with Abbott Laboratories, the manufacturers of Reductil (sibutramine).

Did you know?

Reductil works by acting on neurotransmitters in the brain to enhance the fullfillment from eating food and increase satiety.

Sibutramine has the trade name Meridia in the US and Canada, and the trade name Reductil in Europe and the rest of the world. Both Reductil and Meridia are exactly the same drug, made from sibutramine hydrochloride monohydrate.

Reductil was approved by the FDA in the US for use as a weight loss drug on November 24th, 1997.

Reductil is manufactured by the pharmaceutical company Abbott Laboratories. Its generic name is sibutramine. You may hear your doctor refer to the drug as sibutramine and not Reductil.

The recommended dose of Reductil is 10mg once daily, or 15mg once daily if deemed appropriate by your physician.

Reductil (Meridia) Information Resource

reductil tabletUPDATE:
Reductil has now been withdrawn from sale in the EU due to concern that it could lead to an increased risk of developing heart problems.

Welcome to the Reductil information web site. If you are trying to lose weight, then you might have heard about Reductil, a slimming pill manufactured by the pharmaceutical company Abbott Laboratories. Reductil is a weight loss drug that may be prescribed to you if you have a Body Mass Index, or BMI, greater than 30, or you have a BMI greater than 27 together with other risk factors such as elevated levels of cholesterol or type II diabetes (but NOT high blood pressure).

This site has been designed to inform you about Reductil, and help you decide whether it is right for you. It is also important that you discuss with your doctor whether Reductil is right for you.

UPDATE: Reductil has now been withdrawn from sale in the EU due to concern that it could lead to an increased risk of developing heart problems.

 

Reductil in the UK and EU

Before it was withdrawn, Reductil was approved by the EMEA for use within the EU and was also approved by NICE (the National Institute for Health and Clinical Excellence) for prescription to suitable patients on the NHS on October 17th, 2001.

It is recommended that treatment with Reductil should be stopped if the patient has not been able to lose 2kg of weight during the first 4 weeks on the drug.

Reductil in the US

Reductil was approved by the FDA in the US for use as a weight loss drug on November 24th, 1997.

 

 

Back to top